Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR1D | P28221 | 1/20 | 0.40 |
| ▸ | HTR1B | P28222 | 1/20 | 0.40 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18020389 | 0.94 | PLA2G2A (0.47) | PLA2G2ACYP3A4CYP2D6RAB9AKDM4E | |
| SCHEMBL16169670 | 0.91 | CYP1A2 (0.38) | PLA2G2ACYP3A4CYP2D6RAB9AKDM4E | |
| SCHEMBL16169673 | 0.91 | NOS3 (0.42) | PLA2G2ACYP3A4CYP2D6RAB9AKDM4E | |
| SCHEMBL16169687 | 0.90 | SMN1; SMN2 (0.48) | CYP3A4CYP2D6TSHRLTA4HSMN1; SMN2 | |
| SCHEMBL16419737 | 0.90 | SMN1; SMN2 (0.48) | CYP3A4CYP2D6TSHRLTA4HSMN1; SMN2 | |
| SCHEMBL16172408 | 0.89 | CSF3R (0.40) | PLA2G2ALTA4HHTR1B | |
| SCHEMBL16419742 | 0.88 | LTA4H (0.49) | PLA2G2ACYP3A4CYP2D6RAB9ALTA4H | |
| SCHEMBL16419735 | 0.87 | CYP2D6 (0.45) | CYP3A4CYP2D6RAB9AKDM4ENPC1 | |
| SCHEMBL16419743 | 0.87 | CHRNB2 (0.43) | CYP3A4CYP2D6RAB9AKDM4ENPC1 | |
| SCHEMBL16169676 | 0.86 | RXRA (0.40) | PLA2G2ACYP3A4CYP2D6RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | PLA2G2A 3004/4885CYP3A4 3480/4885CYP2D6 3113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.